Michelle Ward, The Canadian PressPublished Wednesday, November 13, 2019 8:24PM EST Benadryl has for decades been used as a go-to drug to treat everything from bee stings to mysterious toddler hives, but... Read more »
(Reuters) – Nearly twice as many people are dying in the United States from antibiotic-resistant infections than previously believed, U.S. health officials said on Wednesday, as so-called “superbugs” alarm experts with their... Read more »
SHANGHAI (Reuters) – Chinese health officials say the risk of an outbreak of pneumonic plague is minimal after two new cases were confirmed in the capital Beijing this week, the official China... Read more »
OTTAWA — A new report from the international medical journal The Lancet says a child born today will never know a life when his or her health isn’t at risk from a... Read more »
LONDON (Reuters) – A child born today faces multiple and life-long health harms from climate change – growing up in a warmer world with risks of food shortages, infectious diseases, floods and... Read more »
(Reuters Health) – Screening newborns for health risks using genomic sequencing can raise ethical and equity questions, the authors of a new paper warn. Testing newborns for a handful of specific childhood... Read more »
(Reuters Health) – Going back into the operating room for surgery to help a woman whose ovarian cancer has reappeared may not help her live longer – instead, it might shorten her... Read more »
‘There are many other safer options that work as well or better’ than Benadryl and other older antihistamines, says Dr. David Fischer, one of the authors of a recent position paper from... Read more »
FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 18,... Read more »
TORONTO/MONTREAL (Reuters) – Johnson & Johnson’s (JNJ.N) Remicade, a blockbuster drug that treats autoimmune disorders, has steadily lost market share among patients enrolled in the Canadian province of Quebec’s public drug program,... Read more »